Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet concentration in PRP for partial-thickness rotator cuff tendon tears
IRCT20260107068580N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of platelet-rich plasma and methylprednisolone in rotator cuff tear (4 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Tendon repair on MRI. Started May 2026; status: completed.
02
Drugs
platelet-rich plasmamethylprednisolone
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on IRCT20260107068580N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260107068580N1.